Bethesda, MD – According to filings with the U.S. Securities and Exchange Commission, RightEye is raising $3,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Adam Gross played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About RightEye

RightEye is the world’s first commercialized eye-tracking solution for general healthcare and wellness. It is nothing like traditional vision tests. It is a proven, easy-to-use tool, steeped in science and applicable for optometry, medicine and sports. Every day. For every body. With RightEye’s non-invasive, five-minute test, healthcare providers can differentiate themselves by expanding the services they provide, be it for functional vision, reading, brain health or sports performance. With RightEye, it’s not only possible to help patients more, but to help more patients. In fact, don’t take our word for it. Hundreds of doctors, therapists and athletic organizations rely on RightEye to keep their patients’ health, wellness and performance at its peak.

To learn more about RightEye, visit http://righteye.com/

Contact:
Adam Gross, Chief Executive Officer
301-979-7970
adam@righteye.com
https://www.linkedin.com/in/adamtgross/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved